| Alzheimer’s disease is more than age-related memory loss—it’s a serious brain disorder. In the latest episode of the Swiss Connection Science podcast, Swissinfo healthcare reporter Jessica Davis Pluess explores the science, hope, and controversy surrounding new Alzheimer’s drugs like Leqembi and Kisunla. With billions invested and global regulatory decisions diverging, what do these treatments mean for patients and healthcare systems? Tune in now, wherever you get your podcasts. #AlzheimersAwareness #DementiaSupport #BrainHealth #AlzheimersResearch #MemoryCare #AlzheimersDisease #CaregiverSupport #MentalHealthMatters #Neuroscience #SciencePodcast #HealthPodcast #PodcastRecommendations #MedicalNews #PodcastLife #NewPodcastAlert #SwissScience #Switzerland #Swiss--- swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on international events. For more articles, interviews and videos visit swissinfo.ch or subscribe to our YouTube channel. |
Tags: Featured





























